On January 31, 2024, the Board of Directors of Reviv3 Procare Company appointed Jeffrey Brown, Peter Dunne, and Manu Ohri to the Board, effective upon the Company?s expected listing on the NYSE American Stock Exchange (the ?NYSE American Listing?). Mr. Brown will serve on the Board for a term expiring at the Company?s 2024 annual meeting of stockholders. Messrs.

Dunne and Ohri will serve on the Board for a term expiring at the Company?s 2025 annual meeting of stockholders. Messrs. Dunne and Ohri will serve on the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee.

Messrs. Brown, Dunne, and Ohri were not selected to serve on the Board under any arrangement or understanding between them and any other person. The Company is not aware of any transactions with Messrs.

Brown, Dunne, and Ohri that would require disclosure under Item 404(a) of Regulation S-K. Messrs. Dunne and Ohri will participate in the Company?s non-employee director compensation arrangements generally applicable to all of the Company?s non-employee directors. Under the terms of those arrangements and pursuant to the Company?s 2022 Equity Incentive Plan (the ?Plan?), on the date of the NYSE American Listing, Messrs.

Dunne and Ohri will be granted a Restricted Stock Award (as defined in the Plan) of 5,000 shares of the Company?s common stock that will vest on the one year anniversary of the grant.